)
Edge
Extra Everything: The Story of Chipotle
Chipotle's story from a single restaurant to a nationwide chain, through crisis and turnaround, built on one of the strongest models in the industry.
PeptiDream
PeptiDream (4587) investor relations material
PeptiDream Jefferies Global Healthcare Conference 2026 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Jefferies Global Healthcare Conference 2026 summary3 Jun, 2026
Business model and platform technology
Developed a macrocyclic peptide discovery engine, enabling partnerships with major pharmaceutical companies globally.
Focused on five core modalities: oral/injectable therapeutics, RI-PDCs, oligonucleotide delivery, cytotoxic drug delivery, and multifunctional peptides.
Transitioning from a discovery-focused company to one advancing its own clinical pipeline.
Clinical pipeline and development progress
Ended the year with 13 clinical-stage programs, expecting 6-12 more to enter clinical development in 2026.
First four wholly owned compounds will enter the clinic in 2026.
Significant progress in radiopharmaceuticals, with macrocyclic peptides enabling effective tumor targeting.
Oral peptide therapeutics and other modalities are advancing, supported by industry successes.
Modality updates and future outlook
Oligo-PDC and cytotoxic PDC programs are progressing, with first clinical phase I starts expected in 2027.
Strong partnerships in oligonucleotide delivery and cytotoxic PDCs, with Merck collaboration nearing clinical stage.
Multifunctional peptide (MPC) programs are advancing, with more disclosures expected as they near clinical stage.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from PeptiDream
- Q1 2026 revenue rose 12.6% and net loss narrowed, with strong FY2026 growth forecast.4587
Q1 202613 May 2026 - FY2025 revenue fell 60% to ¥18.5B; FY2026 targets ¥32B and 6–12 new clinical programs.4587Q4 202513 Apr 2026
- Record H1 2024 profit and revenue driven by Drug Discovery and Novartis deal expansion.4587Q2 20242 Feb 2026
- Late-stage radiopharma pipeline and AI-driven discovery fuel growth and global partnerships.4587Investor Day 202411 Jan 2026
- FY2024 saw record revenue and profit growth, robust pipeline, and strong guidance for FY2025.4587Q4 202416 Dec 2025
- Radiopharmaceutical and peptide pipeline advances, plus facility investments, fuel strong growth.4587Status Update7 Dec 2025
- Significant revenue decline led to a net loss, but radiopharmaceuticals showed growth.4587Q3 202512 Nov 2025
- Revenue and net income fell, but radiopharma growth and guidance remain strong.4587Q2 20258 Aug 2025
- Revenue and profit soared on Drug Discovery strength, with robust cash flow and pipeline advances.4587Q3 202413 Jun 2025
Next PeptiDream earnings date
Q2 202612 Aug, 2026
PeptiDream
Next PeptiDream earnings date
Q2 202612 Aug, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
)
Frequently asked questions
Explore our global coverage